1. Advancements in interventional glaucoma therapy aim to enhance intraocular pressure (IOP) control and improve long-term outcomes.
2. Selective laser trabeculoplasty (SLT), minimally invasive glaucoma surgeries (MIGS), and procedural pharmaceuticals are gaining traction as alternatives or adjuncts to traditional therapies.
3. Comprehensive IOP control is emphasized by targeting multiple mechanisms—including trabecular and uveoscleral outflow, aqueous suppression, and episcleral venous pressure—to balance aqueous humor production and outflow. 
4. Patients may require multiple medications or retreatment to achieve target IOP levels.
5. A combination of treatments can minimize or eliminate the need for daily self-dosing of topical medications, and reduce medication burden for patients.

Source: Ophthalmology and Therapy